Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Unwinding

<< Previous

Bullboard Posts

Next >>

Post by CaptainConnon Feb 01, 2021 12:00pm

231 Views

Post# 32436908

Unwinding

A lot of people had piled into it betting on news about LSE or Nasdaq listing but instead they are making progress to be on NEO. Getting dumped because of that. Unless we get a reversal today, I expect a return to 44 cents and perhaps even 40 cents. Glta

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks